Mostafa has served as CEO of PDC CRO since 2020, overseeing clinical trial and consultancy and life science solutions across the MEA region. Since 2024, the company has expanded across Africa, conducting trials for various therapeutic indications focused on infectious and rare-diseases. In 2024, PDC CRO also partnered with Uncommon Cures to advance rare disease research. In 2025, it announced a strategic partnership with U.S.-based Medable to expand clinical trial's AI-driven digital solutions in the MEA region. Mostafa has over 20 years of experience in clinical research and the pharmaceutical business.